Login / Signup
Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?
Gabriel Herrero-Beaumont
Raquel Largo
Published in:
Annals of the rheumatic diseases (2020)
Keyphrases
</>
low grade
high grade
knee osteoarthritis
drug induced